Exploring Barriers to Inclusivity: Systematic Analysis of Exclusion Criteria and Potential Bias in Clinical Cancer Trials for Psychiatric and Neurological Conditions in European Protocols
Psycho-Oncology · 2025
DOI: 10.1002/pon.70182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psycho-Oncology, 2025. Verfasst von Margherita Dahò und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, Educational Science and Human Movement, University of Palermo, Palermo, Italy. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Breast Neoplasms, Patient Selection, Mental Disorders. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beacon Cancer Care funded by the European Union's EU4Health Program under Grant Agreement Number: 101080005.
Abstract (Originalsprache)
Background
Cancer clinical trials often employ exclusion criteria that can impact vulnerable populations, particularly individuals with psychological, psychiatric, or neurological conditions.
Aims
This study aimed to analyze the prevalence and nature of exclusion criteria in clinical trials for prostate, breast, and lung cancers.
Methods
The EU Clinical Trials Register identified 51 protocols uploaded between 2022 and 2024. Thematic content analysis categorized exclusion criteria, and the justifications provided, while frequency analysis quantified their prevalence.
Results
After excluding five protocols (two non‐English and three inaccessible), the final dataset comprised 46 protocols: 13 for prostate cancer (22.8%), 24 for breast cancer (42.1%), and 9 for lung cancer (15.8%). Exclusion criteria targeting vulnerable populations were present in 78.3% of protocols, categorized into five themes: psychiatric conditions (24.6%), neurological conditions (22.8%), other psychological conditions (22.8%), legal/guardianship status (5.3%), and unspecified conditions (24.6%). Compliance concerns (39.1%) were the most common justification, followed by informed consent challenges (32.6%), safety risks (13%), drug interference (10.9%), and not in the best interest (4.3%). Notably, 29.1% of protocols lacked justification for exclusions, raising ethical and transparency concerns.
Conclusions
The exclusion of vulnerable populations may limit the inclusivity and generalizability of cancer research. Heuristic biases and systemic practices can potentially influence this. Exploring the role of these factors and considering adaptive trial designs, along with providing detailed justifications for exclusion criteria, could support more equitable and representative clinical research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychology, Educational Science and Human Movement, University of Palermo, Palermo, Italy.
- WeSearch Lab - Laboratory of Behavioral Observation and Research on Human Development, University of Palermo, Palermo, Italy.
- Applied Research Division for Cognitive and Psychological Science, IEO European Institute of Oncology IRCCS, Milan, Italy.
- Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
- Centre for Biomedical Ethics and Law, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
- Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo, Palermo, Italy.
ORCID-Profile: Margherita Dahò, Veronica Coppini
Förderung
- Beacon Cancer Care funded by the European Union's EU4Health Program under Grant Agreement Number: 101080005
Zitieren
APA
Dahò, M., Coppini, V., Ferrari, M. V., Ferraris, G., Sanchini, V., Monzani, D., Grasso, R., Agnello, C., Badalamenti, G., Algeri, L., & Pravettoni, G. (2025). Exploring Barriers to Inclusivity: Systematic Analysis of Exclusion Criteria and Potential Bias in Clinical Cancer Trials for Psychiatric and Neurological Conditions in European Protocols. Psycho-Oncology. https://doi.org/10.1002/pon.70182
Vancouver
Dahò M, Coppini V, Ferrari MV, Ferraris G, Sanchini V, Monzani D, et al. Exploring Barriers to Inclusivity: Systematic Analysis of Exclusion Criteria and Potential Bias in Clinical Cancer Trials for Psychiatric and Neurological Conditions in European Protocols. Psycho-Oncology. 2025. doi:10.1002/pon.70182
BibTeX
@article{Dah2025,
author = {Dahò, Margherita and Coppini, Veronica and Ferrari, Maria Vittoria and Ferraris, Giulia and Sanchini, Virginia and Monzani, Dario and Grasso, Roberto and Agnello, Chiara and Badalamenti, Giuseppe and Algeri, Laura and Pravettoni, Gabriella},
title = {Exploring Barriers to Inclusivity: Systematic Analysis of Exclusion Criteria and Potential Bias in Clinical Cancer Trials for Psychiatric and Neurological Conditions in European Protocols},
journal = {Psycho-Oncology},
year = {2025},
doi = {10.1002/pon.70182}
}
EUVIMED